← All candidates
56 insider filings on record.
56 filings on record.
TECHBIO-TECHNE Corp
NasdaqGS · Healthcare · $11.34B
$72.34
+0.10% · Sep 15
56 insider filings on record.
None of them an open-market buy in the last year.
Price · 1Y · daily● 1 sell
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$11.34B
Float
156.2M
100% public
Short % float
Pro
Price / profit
62.4
Price / future profit
31.4
Price / sales
9.3
Congress
▸ Disclosures lag trades by 30–45 days.
7 disclosures12 mo
MemberTypeAmountOwnerTradedFiled
April McClain Delaneytraded 26 Mar · filed 6 Apr · childSell (part)$1K–$15Kchild26 Mar174d ago6 Apr163d ago
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
51 more transactions on Pro →Context
Wall St
$69.08 avg target
-4.5% vs today · 12 analysts · consensus Hold
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
2 of 4 quarters beat
Q1 '26$0.53 act−$0.00
Q4 '25$0.46 act+$0.03
Q3 '25$0.42 act−$0.00
Q2 '25$0.53 act+$0.03
Coverage
The $11 Billion Reason TECH Stock Is Up TodayBarchart · 06-26Merck KGaA to acquire Bio-Techne in $11.3 billion dealQuartz · 06-26Bio-Techne (TECH) Agrees To $11.5 Billion Merck KGaA BuyoutSimply Wall St. · 06-26Germany’s Merck Pumps Up Life Sciences Biz with $11.3B Bio-Techne DealThe Daily Upside · 06-26
The file stays open
56 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice